{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:16:46Z","timestamp":1791047806162,"version":"4.1.0"},"reference-count":172,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>The Japanese encephalitis virus (JEV) remains a major cause of viral encephalitis in Asia, and recent epidemiological shifts driven by the predominance of genotype I and the re-emergence of genotype V have renewed concerns regarding control efforts. Licensed vaccines have a reduced incidence of more than 90% in several endemic regions; however, evidence of reduced cross-neutralization against heterologous genotypes indicates that vaccines derived from genotype III strains may not fully match the evolving antigenic landscape. This review synthesizes current knowledge on vaccine performance, genotype-driven antigenic variation, and implications for future strain alignment. Emerging platforms, including mRNA, DNA, virus-like particles, and structure-guided recombinant antigens, have been evaluated for their potential to enhance cross-genotype breadth, scalability, and thermostability. We also summarize the progress in antiviral discovery targeting viral nonstructural proteins, host pathways, and monoclonal antibody development, along with immunomodulatory and neuroprotective strategies. Translational challenges, such as blood\u2013brain barrier penetration, therapeutic timing, and durability of immunity, have been highlighted as key barriers to clinical application. By integrating molecular, immunological, and epidemiological evidence, this review outlines strategic directions for developing broad-spectrum vaccines and therapeutics capable of addressing the evolving genetic and ecological landscape of JEV.<\/jats:p>","DOI":"10.3390\/pathogens14121204","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:43:22Z","timestamp":1764157402000},"page":"1204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus"],"prefix":"10.3390","volume":"14","author":[{"given":"Jae-Yeon","family":"Park","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6382-3434","authenticated-orcid":false,"given":"Hye-Mi","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tarantola, A., Goutard, F., Newton, P., de Lamballerie, X., Lortholary, O., Cappelle, J., and Buchy, P. (2014). Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the mekong region. PLoS Neglected Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002533"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e51027","DOI":"10.7554\/eLife.51027","article-title":"Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000\u20132015","volume":"9","author":"Quan","year":"2020","journal-title":"eLife"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.15585\/mmwr.mm6622a3","article-title":"Japanese Encephalitis Surveillance and Immunization\u2014Asia and Western Pacific Regions, 2016","volume":"66","author":"Heffelfinger","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Li, W., Feng, Y., Zhong, H., Jiang, M., Zhang, J., Lin, S., Chen, N., He, S., Zhang, K., and Fu, S. (2024). Incongruence between confirmed and suspected clinical cases of Japanese encephalitis virus infection. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1302314"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Letson, G.W., Marfin, A.A., Mooney, J., Minh, H.V., Hills, S.L., and The JE Vaccine Global Impact Assessment Team (2024). Impact of vaccination against Japanese encephalitis in endemic countries. PLoS Neglected Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012390"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): A case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ngwe Tun, M.M., Kyaw, A.K., Nwe, K.M., Inoue, S., Thant, K.Z., and Morita, K. (2021). Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar. Vaccines, 9.","DOI":"10.3390\/vaccines9060568"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-021-00371-y","article-title":"Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity","volume":"6","author":"Davis","year":"2021","journal-title":"Npj Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41541-024-00903-2","article-title":"A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge","volume":"9","author":"Harrison","year":"2024","journal-title":"Npj Vaccines"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/651271","article-title":"Japanese encephalitis: New options for active immunization","volume":"50","author":"Halstead","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chan, K.R., Ismail, A.A., Thergarajan, G., Raju, C.S., Yam, H.C., Rishya, M., and Sekaran, S.D. (2022). Serological cross-reactivity among common flaviviruses. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.975398"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/infdis\/jiae589","article-title":"Genotype III-Based Japanese Encephalitis Vaccines Exhibit Diminished Neutralizing Response to Reemerging Genotype V","volume":"231","author":"Lee","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1128\/JVI.02050-14","article-title":"Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity","volume":"88","author":"Han","year":"2014","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Xia, Q., Yang, Y., Zhang, Y., Zhou, L., Ma, X., Xiao, C., Zhang, J., Li, Z., Liu, K., and Li, B. (2023). Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategies. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1302101"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yun, B.R., Kwon, J.Y., Noh, B.E., Cho, S., Kwak, D., and Lee, H.I. (2025). Genetic shifts of Japanese encephalitis virus (JEV) in mosquitoes in the Republic of Korea, 2017\u20132022. PLoS Neglected Trop. Dis., 19.","DOI":"10.1371\/journal.pntd.0013258"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2362392","DOI":"10.1080\/22221751.2024.2362392","article-title":"Characterization of genotype V Japanese encephalitis virus isolates from Republic of Korea","volume":"13","author":"Lee","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhang, H., Zhang, Y., Li, D., Zheng, J., Zhang, J., Li, Z., Liu, K., Li, B., Shao, D., and Qiu, Y. (2025). Partial protective efficacy of the current licensed Japanese encephalitis live vaccine against the emerging genotype I Japanese encephalitis virus isolated from sheep. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1513261"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1874357901812010121","article-title":"Japanese Encephalitis: A Brief Review on Indian Perspectives","volume":"12","author":"Kulkarni","year":"2018","journal-title":"Open Virol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s43440-022-00355-2","article-title":"Antiviral drug research for Japanese encephalitis: An updated review","volume":"74","author":"Joe","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20151517","article-title":"Human T cell responses to Japanese encephalitis virus in health and disease","volume":"213","author":"Turtle","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e70608","DOI":"10.1002\/jmv.70608","article-title":"Japanese Encephalitis Virus Genotype 5 Infectious Clone and Reporter System for Antiviral Evaluation","volume":"97","author":"Park","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Park, J.Y., Lee, H.M., Jun, S.H., Kamitani, W., Kim, O., and Shin, H.J. (2024). Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine. Vaccines, 12.","DOI":"10.3390\/vaccines12060597"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s44197-023-00110-7","article-title":"Incidence of Japanese Encephalitis and Acute Encephalitis Syndrome Hospitalizations in the Medium-Endemic Region in Central India","volume":"13","author":"Tandale","year":"2023","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Park, J.Y., and Lee, H.M. (2025). Managing Japanese Encephalitis Virus as a Veterinary Infectious Disease Through Animal Surveillance and One Health Control Strategies. Life, 15.","DOI":"10.3390\/life15081260"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, S., Liu, Y., Guo, J., Wang, P., Zhang, L., Xiao, G., and Wang, W. (2017). Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection. J. Virol., 91.","DOI":"10.1128\/JVI.01055-17"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/JVI.78.10.5133-5138.2004","article-title":"Accumulation of a 3\u2032-terminal genome fragment in Japanese encephalitis virus-infected mammalian and mosquito cells","volume":"78","author":"Lin","year":"2004","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mazeaud, C., Freppel, W., and Chatel-Chaix, L. (2018). The Multiples Fates of the Flavivirus RNA Genome During Pathogenesis. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00595"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3201\/eid2605.190977","article-title":"Genetic Characterization of Japanese Encephalitis Virus Genotype 5 Isolated from Patient, South Korea, 2015","volume":"26","author":"Woo","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism","volume":"26","author":"Glasner","year":"2019","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yun, S.I., and Lee, Y.M. (2018). Early Events in Japanese Encephalitis Virus Infection: Viral Entry. Pathogens, 7.","DOI":"10.3390\/pathogens7030068"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00705-022-05481-z","article-title":"Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies","volume":"167","author":"Kumar","year":"2022","journal-title":"Arch. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virol.2022.02.001","article-title":"The interactions of flaviviruses with cellular receptors: Implications for virus entry","volume":"568","author":"Anwar","year":"2022","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nain, M., Mukherjee, S., Karmakar, S.P., Paton, A.W., Paton, J.C., Abdin, M.Z., Basu, A., Kalia, M., and Vrati, S. (2017). GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry and Replication in Mammalian Cells. J. Virol., 91.","DOI":"10.1128\/JVI.02274-16"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Yadav, P., Chakraborty, P., Jha, N.K., Dewanjee, S., Jha, A.K., Panda, S.P., Mishra, P.C., Dey, A., and Jha, S.K. (2022). Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases. Viruses, 14.","DOI":"10.3390\/v14122686"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100994","DOI":"10.1016\/j.mam.2021.100994","article-title":"Pathobiology of Japanese encephalitis virus infection","volume":"81","author":"Sharma","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ye, J., Chen, Z., Li, Y., Zhao, Z., He, W., Zohaib, A., Song, Y., Deng, C., Zhang, B., and Chen, H. (2017). Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-kappaB. J. Virol., 91.","DOI":"10.1128\/JVI.00039-17"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-023-02891-x","article-title":"Type I\/type III IFN and related factors regulate JEV infection and BBB endothelial integrity","volume":"20","author":"Zhang","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chen, S.T., Liu, R.S., Wu, M.F., Lin, Y.L., Chen, S.Y., Tan, D.T., Chou, T.Y., Tsai, I.S., Li, L., and Hsieh, S.L. (2012). CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002655"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1743-422X-9-135","article-title":"Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model","volume":"9","author":"Li","year":"2012","journal-title":"Virol. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/vim.2013.0016","article-title":"Innate immune mechanisms in Japanese encephalitis virus infection: Effect on transcription of pattern recognition receptors in mouse neuronal cells and brain tissue","volume":"26","author":"Fadnis","year":"2013","journal-title":"Viral Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","article-title":"Japanese encephalitis\u2014The prospects for new treatments","volume":"14","author":"Turtle","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nazmi, A., Dutta, K., and Basu, A. (2011). RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021761"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2020.04.060","article-title":"Role of pattern recognition receptors and interferon-beta in protecting bat cell lines from encephalomyocarditis virus and Japanese encephalitis virus infection","volume":"527","author":"Tarigan","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","article-title":"Flavivirus NS1: A multifaceted enigmatic viral protein","volume":"13","author":"Rastogi","year":"2016","journal-title":"Virol. J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wan, J., Wang, T., Xu, J., Ouyang, T., Wang, Q., Zhang, Y., Weng, S., Li, Y., Wang, Y., and Xin, X. (2021). Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit. eBioMedicine, 67.","DOI":"10.1016\/j.ebiom.2021.103353"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, G., Teleki, C., and Wang, T. (2018). Memory T Cells in Flavivirus Vaccination. Vaccines, 6.","DOI":"10.3390\/vaccines6040073"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","article-title":"Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers","volume":"29","author":"Klade","year":"2011","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bonaparte, M., Dweik, B., Feroldi, E., Meric, C., Bouckenooghe, A., Hildreth, S., Hu, B., Yoksan, S., and Boaz, M. (2014). Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-156"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody","volume":"87","author":"Larena","year":"2013","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41541-021-00338-z","article-title":"The future of Japanese encephalitis vaccination: Expert recommendations for achieving and maintaining optimal JE control","volume":"6","author":"Vannice","year":"2021","journal-title":"Npj Vaccines"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rathore, A.P.S., and St John, A.L. (2020). Cross-Reactive Immunity Among Flaviviruses. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00334"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kotaki, T., Nagai, Y., Yamanaka, A., Konishi, E., and Kameoka, M. (2022). Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection. Vaccines, 10.","DOI":"10.3390\/vaccines10091411"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Yen, L.C., Chen, H.W., Ho, C.L., Lin, C.C., Lin, Y.L., Yang, Q.W., Chiu, K.C., Lien, S.P., Lin, R.J., and Liao, C.L. (2023). Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00938-y"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/jtm\/tay009","article-title":"Japanese encephalitis: The vectors, ecology and potential for expansion","volume":"25","author":"Pearce","year":"2018","journal-title":"J. Travel Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4269\/ajtmh.2012.12-0315","article-title":"Occurrence of Japanese encephalitis virus mosquito vectors in relation to urban pig holdings","volume":"87","author":"Lindahl","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Li, F., Feng, Y., Wang, G., Zhang, W., Fu, S., Wang, Z., Yin, Q., Nie, K., Yan, J., and Deng, X. (2023). Tracing the spatiotemporal phylodynamics of Japanese encephalitis virus genotype I throughout Asia and the western Pacific. PLoS Neglected Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011192"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12985-015-0278-4","article-title":"Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964\u20132011: Genotype replacement","volume":"12","author":"Do","year":"2015","journal-title":"Virol. J."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mackenzie, J.S., Williams, D.T., van den Hurk, A.F., Smith, D.W., and Currie, B.J. (2022). Japanese Encephalitis Virus: The Emergence of Genotype IV in Australia and Its Potential Endemicity. Viruses, 14.","DOI":"10.3390\/v14112480"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Xu, G., Gao, T., Wang, Z., Zhang, J., Cui, B., Shen, X., Zhou, A., Zhang, Y., Zhao, J., and Liu, H. (2023). Re-Emerged Genotype IV of Japanese Encephalitis Virus Is the Youngest Virus in Evolution. Viruses, 15.","DOI":"10.3390\/v15030626"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhang, W., Yin, Q., Wang, H., and Liang, G. (2023). The reemerging and outbreak of genotypes 4 and 5 of Japanese encephalitis virus. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1292693"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kishore, K.J.N., Praharaj, M.R., Tanuj, G.N., Sahoo, A.P., Ambati, T., Pyatla, M.K.G., Peela, S.M., Dhanze, H., Gandham, R.K., and Majumdar, S. (2025). Tracing the evolutionary trajectory of Japanese encephalitis virus across hosts and countries. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-03277-0"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Schuh, A.J., Ward, M.J., Brown, A.J., and Barrett, A.D. (2013). Phylogeography of Japanese encephalitis virus: Genotype is associated with climate. PLoS Neglected Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002411"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Fernandez, E., Kose, N., Edeling, M.A., Adhikari, J., Sapparapu, G., Lazarte, S.M., Nelson, C.A., Govero, J., Gross, M.L., and Fremont, D.H. (2018). Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus. mBio, 9.","DOI":"10.1128\/mBio.00008-18"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e34372","DOI":"10.1016\/j.heliyon.2024.e34372","article-title":"Generation of soluble, immunoreactive recombinant JEV E protein through a simplified inclusion body extraction and refolding approach in vitro","volume":"10","author":"Shen","year":"2024","journal-title":"Heliyon"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Cao, L., Fu, S., Gao, X., Li, M., Cui, S., Li, X., Cao, Y., Lei, W., Lu, Z., and He, Y. (2016). Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus. PLoS Neglected Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004686"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Peng, C., Qin, H., Yu, F., Hao, Y., Yuan, Y., Ma, W., Zhang, D., Xiao, P., and Li, N. (2025). Epidemiology, Transmission, and Evolution of Japanese Encephalitis Virus. Microorganisms, 13.","DOI":"10.3390\/microorganisms13061226"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1080\/21645515.2021.1969852","article-title":"Safety of Japanese encephalitis vaccines","volume":"17","author":"Hu","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.vaccine.2005.10.054","article-title":"The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan","volume":"24","author":"Yang","year":"2006","journal-title":"Vaccine"},{"key":"ref_71","first-page":"1","article-title":"Japanese encephalitis vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fischer","year":"2010","journal-title":"MMWR Recomm. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3345\/cep.2020.01984","article-title":"Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea","volume":"65","author":"Kwak","year":"2022","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0264-410X(00)00037-2","article-title":"New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998","volume":"18","author":"Tsai","year":"2000","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cid\/cis883","article-title":"Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes","volume":"56","author":"Erra","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/21645515.2014.983412","article-title":"Product review on the JE vaccine IXIARO","volume":"11","author":"Firbas","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.4161\/21645515.2014.980197","article-title":"Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review","volume":"10","author":"Li","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_77","unstructured":"Centers for Disease Control and Prevention (2013). Use of Japanese encephalitis vaccine in children: Recommendations of the advisory committee on immunization practices, 2013. MMWR Morb. Mortal. Wkly. Rep., 62, 898\u2013900."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV((R)): A Yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"Appaiahgari","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/INF.0000000000001615","article-title":"Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region","volume":"36","author":"Dubischar","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2019.03.030","article-title":"Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO(R) in healthy adults: A five year follow-up study","volume":"37","author":"Taucher","year":"2019","journal-title":"Vaccine"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/INF.0000000000002124","article-title":"Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose","volume":"37","author":"Kadlecek","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: A case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Turtle, L., Tatullo, F., Bali, T., Ravi, V., Soni, M., Chan, S., Chib, S., Venkataswamy, M.M., Fadnis, P., and Yaich, M. (2017). Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE\/Dengue Co-Endemic Area. PLoS Neglected Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005263"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.vaccine.2021.06.023","article-title":"Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis","volume":"39","author":"Xu","year":"2021","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4161\/hv.29743","article-title":"A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea","volume":"10","author":"Kim","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40121-013-0018-2","article-title":"Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine","volume":"2","author":"Chin","year":"2013","journal-title":"Infect. Dis. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: Review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"ref_90","unstructured":"(CDC) Centers for Disease Control and Prevention (2025, October 24). ACIP Evidence to Recommendations Framework: Japanese Encephalitis Vaccine in Children, Available online: https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/JE-etr-framework.html."},{"key":"ref_91","unstructured":"(CDC) Centers for Disease Control and Prevention (2025, October 24). Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Japanese Encephalitis Vaccine in Children, Available online: https:\/\/www.cdc.gov\/acip\/grade\/je-child.html."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1016\/j.vaccine.2020.06.008","article-title":"Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV(R)) in Taiwan, 2017\u201318","volume":"38","author":"Ma","year":"2020","journal-title":"Vaccine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4161\/hv.23087","article-title":"Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children","volume":"9","author":"Feroldi","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_95","unstructured":"(2015). Japanese Encephalitis Vaccines: WHO position paper\u2014February 2015. Wkly. Epidemiol. Rec., 90, 69\u201387."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","article-title":"Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO(R), IC51","volume":"29","author":"Eder","year":"2011","journal-title":"Vaccine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1016\/j.vaccine.2010.05.069","article-title":"Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51","volume":"28","author":"Eder","year":"2010","journal-title":"Vaccine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): Results of a randomized trial with 26,239 subjects","volume":"176","author":"Liu","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","article-title":"Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials","volume":"28","author":"Torresi","year":"2010","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/INF.0000000000001494","article-title":"Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization","volume":"36","author":"Kosalaraksa","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Filgueira, L., and Lannes, N. (2019). Review of Emerging Japanese Encephalitis Virus: New Aspects and Concepts about Entry into the Brain and Inter-Cellular Spreading. Pathogens, 8.","DOI":"10.3390\/pathogens8030111"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sistrom, M., Andrews, H., and Edwards, D.L. (2024). Comparative genomics of Japanese encephalitis virus shows low rates of recombination and a small subset of codon positions under episodic diversifying selection. PLoS Neglected Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0011459"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Chen, T., Zhu, S., Wei, N., Zhao, Z., Niu, J., Si, Y., Cao, S., and Ye, J. (2022). Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection. Viruses, 14.","DOI":"10.3390\/v14061121"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zhu, J., He, C., Liu, Y., Chen, M., Zhang, J., Chen, D., Ni, H., and Wen, J. (2024). An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1472824"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41541-023-00656-4","article-title":"An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection","volume":"8","author":"Bollman","year":"2023","journal-title":"Npj Vaccines"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3892\/mmr.2015.3419","article-title":"Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB\/c mouse granulocyte-macrophage colony-stimulating factor","volume":"12","author":"Zhai","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese encephalitis: The virus and vaccines","volume":"10","author":"Yun","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jbiosc.2012.06.012","article-title":"Production of Japanese encephalitis virus-like particles using the baculovirus-insect cell system","volume":"114","author":"Yamaji","year":"2012","journal-title":"J. Biosci. Bioeng."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Tarbe, M., Dong, W., Hu, G., Xu, Y., Sun, J., Grayo, S., Chen, X., Qin, C., Zhao, J., and Liu, L. (2020). Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.577546"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.micinf.2005.05.023","article-title":"Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis","volume":"8","author":"Appaiahgari","year":"2006","journal-title":"Microbes Infect."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Han, X., Cai, Z., Dai, Y., Huang, H., Cao, X., Wang, Y., Fang, Y., Liu, G., Zhang, M., and Zhang, Y. (2022). Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.927674"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2343910","DOI":"10.1080\/22221751.2024.2343910","article-title":"Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus","volume":"13","author":"Kim","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Adugna, T., Niu, Q., Guan, G., Du, J., Yang, J., Tian, Z., and Yin, H. (2024). Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: A systematic review. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1505612"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JVI.72.6.4925-4930.1998","article-title":"Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes","volume":"72","author":"Konishi","year":"1998","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.vaccine.2003.10.011","article-title":"In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine","volume":"22","author":"Wu","year":"2004","journal-title":"Vaccine"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2016.10.001","article-title":"Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs","volume":"34","author":"Sheng","year":"2016","journal-title":"Vaccine"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12985-020-01400-3","article-title":"Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China","volume":"17","author":"Zheng","year":"2020","journal-title":"Virol. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0264-410X(98)00156-X","article-title":"Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes","volume":"17","author":"Nam","year":"1999","journal-title":"Vaccine"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Higuchi, A., Toriniwa, H., Komiya, T., and Nakayama, T. (2016). Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150213"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2079323","DOI":"10.1080\/21645515.2022.2079323","article-title":"Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses","volume":"18","author":"Shoushtari","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Zhang, A., Mo, X., Zhou, N., Wang, Y., Wei, G., Hao, Z., and Chen, K. (2020). Identification of Chitinolytic Enzymes in Chitinolyticbacter meiyuanensis and Mechanism of Efficiently Hydrolyzing Chitin to N-Acetyl Glucosamine. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.572053"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"199376","DOI":"10.1016\/j.virusres.2024.199376","article-title":"Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8(+)T cells","volume":"345","author":"Duan","year":"2024","journal-title":"Virus Res."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Dos Santos Franco, L., Gushi, L.T., Luiz, W.B., and Amorim, J.H. (2019). Seeking Flavivirus Cross-Protective Immunity. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02260"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: Lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Deng, Y.Q., Dai, J.X., Ji, G.H., Jiang, T., Wang, H.J., Yang, H.O., Tan, W.L., Liu, R., Yu, M., and Ge, B.X. (2011). A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016059"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e38970","DOI":"10.7554\/eLife.38970","article-title":"Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody","volume":"7","author":"Shen","year":"2018","journal-title":"eLife"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Zhang, N., Li, C., Jiang, S., and Du, L. (2020). Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines. Vaccines, 8.","DOI":"10.3390\/vaccines8030481"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1016\/j.vaccine.2022.09.012","article-title":"Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodies","volume":"40","author":"Yamanaka","year":"2022","journal-title":"Vaccine"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"He, J., Ding, X., Zhao, J., Zeng, J., Zhou, Y., Xiao, W., Hua, D., Liu, M., Guo, H., and Zhang, Y. (2024). A novel pan-epitope based nanovaccine self-assembled with CpG enhances immune responses against flavivirus. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-03031-0"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Dutta, S.K., and Langenburg, T. (2023). A Perspective on Current Flavivirus Vaccine Development: A Brief Review. Viruses, 15.","DOI":"10.3390\/v15040860"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"taaf006","DOI":"10.1093\/jtm\/taaf006","article-title":"Long-term immunogenicity of a single-dose live recombinant chimeric Japanese encephalitis vaccine in adults","volume":"32","author":"Mills","year":"2025","journal-title":"J. Travel Med."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Fan, Y.C., Chen, J.M., Chiu, H.C., Chen, Y.Y., Lin, J.W., Shih, C.C., Chen, C.M., Chang, C.C., Chang, G.J., and Chiou, S.S. (2012). Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Neglected Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001834"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Vista, F.E.S., Dalmacio, L.M.M., Solis, P.R., Maramba-Lazarte, C.N.C., Lang, D.M., Rothman, A.L., and de Paz-Silava, S.L.M. (2025). Antibody responses to Japanese encephalitis virus and dengue virus serotype 2 in children from an orthoflavivirus endemic region after IMOJEV vaccination. PLoS Neglected Trop. Dis., 19.","DOI":"10.1371\/journal.pntd.0013550"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Salem, G.M., Galula, J.U., Wu, S.R., Liu, J.H., Chen, Y.H., Wang, W.H., Wang, S.F., Song, C.S., Chen, F.C., and Abarientos, A.B. (2024). Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus. Commun. Biol., 7.","DOI":"10.1038\/s42003-023-05661-w"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Chen, S., Lurong, Q., and Qi, Z. (2023). Recent Advances in Antivirals for Japanese Encephalitis Virus. Viruses, 15.","DOI":"10.3390\/v15051033"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Srivastava, K.S., Jeswani, V., Pal, N., Bohra, B., Vishwakarma, V., Bapat, A.A., Patnaik, Y.P., Khanna, N., and Shukla, R. (2023). Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines. Vaccines, 11.","DOI":"10.3390\/vaccines11040742"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Haviernik, J., Stefanik, M., Fojtikova, M., Kali, S., Tordo, N., Rudolf, I., Hubalek, Z., Eyer, L., and Ruzek, D. (2018). Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Viruses, 10.","DOI":"10.20944\/preprints201802.0134.v1"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Sacramento, C.Q., de Melo, G.R., de Freitas, C.S., Rocha, N., Hoelz, L.V., Miranda, M., Fintelman-Rodrigues, N., Marttorelli, A., Ferreira, A.C., and Barbosa-Lima, G. (2017). The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci. Rep., 7.","DOI":"10.1038\/srep46772"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Adhikari, J., Heffernan, J., Edeling, M., Fernandez, E., Jethva, P.N., Diamond, M.S., Fremont, D.H., and Gross, M.L. (2024). Epitope Mapping of Japanese Encephalitis Virus Neutralizing Antibodies by Native Mass Spectrometry and Hydrogen\/Deuterium Exchange. Biomolecules, 14.","DOI":"10.3390\/biom14030374"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Chen, D., Zhang, J., Liu, Y., Zhu, J., Chen, J., Ni, H., and Wen, J. (2024). A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1508923"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4149\/av_2011_02_165","article-title":"Enhanced protection of mice against Japanese encephalitis virus infection by combinations of monoclonal antibodies to glycoprotein E","volume":"55","author":"Gupta","year":"2011","journal-title":"Acta Virol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Abdeldaim, D.T., and Schindowski, K. (2023). Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15102402"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Kim, J.A., Seong, R.K., Kumar, M., and Shin, O.S. (2018). Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models. Viruses, 10.","DOI":"10.3390\/v10020072"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/596309","article-title":"Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India","volume":"48","author":"Kumar","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3988\/jcn.2021.17.3.428","article-title":"Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-alpha2b","volume":"17","author":"Son","year":"2021","journal-title":"J. Clin. Neurol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000321483","article-title":"Mycophenolic acid inhibits replication of Japanese encephalitis virus","volume":"57","author":"Sebastian","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e29382","DOI":"10.1002\/jmv.29382","article-title":"Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus-based high-throughput screening","volume":"96","author":"Yin","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Diani, E., Lagni, A., Lotti, V., Tonon, E., Cecchetto, R., and Gibellini, D. (2023). Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview. Microorganisms, 11.","DOI":"10.3390\/microorganisms11102427"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Guo, J., Mi, Y., Guo, Y., Bai, Y., Wang, M., Wang, W., and Wang, Y. (2024). Current Advances in Japanese Encephalitis Virus Drug Development. Viruses, 16.","DOI":"10.3390\/v16020202"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"890586","DOI":"10.1155\/2012\/890586","article-title":"The involvement of microglial cells in Japanese encephalitis infections","volume":"2012","author":"Thongtan","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/glia.20474","article-title":"Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis","volume":"55","author":"Ghoshal","year":"2007","journal-title":"Glia"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/infdis\/jiu179","article-title":"Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis","volume":"210","author":"Ye","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/cns.13265","article-title":"Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus","volume":"25","author":"Peng","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Huang, Y., Zhou, B., Hong, S., and Cai, Y. (2024). A case report and literature review on tocilizumab-cured acute necrotizing encephalopathy caused by influenza A virus. Front. Pediatr., 12.","DOI":"10.3389\/fped.2024.1351478"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Kitidee, K., Samutpong, A., Pakpian, N., Wisitponchai, T., Govitrapong, P., Reiter, R.J., and Wongchitrat, P. (2023). Antiviral effect of melatonin on Japanese encephalitis virus infection involves inhibition of neuronal apoptosis and neuroinflammation in SH-SY5Y cells. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-33254-4"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Komorowska, J., Watroba, M., Bednarzak, M., Grabowska, A.D., and Szukiewicz, D. (2024). Anti-Inflammatory Action of Resveratrol in the Central Nervous System in Relation to Glucose Concentration-An In Vitro Study on a Blood-Brain Barrier Model. Int. J. Mol. Sci., 25.","DOI":"10.21203\/rs.3.rs-3869532\/v1"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13287-017-0486-5","article-title":"Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality","volume":"8","author":"Bian","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jmv.25396","article-title":"Memantine can relieve the neuronal impairment caused by neurotropic virus infection","volume":"91","author":"Sun","year":"2019","journal-title":"J. Med. Virol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1096\/fba.2022-00071","article-title":"Bone marrow-derived extracellular vesicles modulate the abundance of infiltrating immune cells in the brain and exert an antiviral effect against the Japanese encephalitis virus","volume":"4","author":"Soni","year":"2022","journal-title":"FASEB BioAdv."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e70033","DOI":"10.1002\/jev2.70033","article-title":"Extracellular vesicles promote the infection and pathogenicity of Japanese encephalitis virus","volume":"14","author":"Xiong","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/acs.jproteome.2c00563","article-title":"Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection","volume":"22","author":"Bharucha","year":"2023","journal-title":"J. Proteome Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2022.03.010","article-title":"A systematic review of brain imaging findings in neurological infection with Japanese encephalitis virus compared with Dengue virus","volume":"119","author":"Pichl","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Ferreira, A.C., Zaverucha-do-Valle, C., Reis, P.A., Barbosa-Lima, G., Vieira, Y.R., Mattos, M., Silva, P.P., Sacramento, C., de Castro Faria Neto, H.C., and Campanati, L. (2017). Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-09797-8"},{"key":"ref_166","first-page":"375","article-title":"Suramin inhibits the in vitro expression of encephalitis B virus proteins NS3 and E","volume":"23","author":"Xu","year":"2003","journal-title":"J. Huazhong Univ. Sci. Technol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00705-021-05283-9","article-title":"Autophagy inhibitors alleviate Japanese encephalitis virus-induced cerebral inflammation in mice","volume":"167","author":"Zhang","year":"2022","journal-title":"Arch. Virol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis","volume":"105","author":"Mishra","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1128\/JVI.02732-05","article-title":"Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2","volume":"80","author":"Liang","year":"2006","journal-title":"J. Virol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Moon, J.H., Hong, J.M., Seol, J.W., Park, B.Y., Eo, S.K., and Park, S.Y. (2023). Melatonin inhibits Japanese encephalitis virus replication and neurotoxicity via calcineurin-autophagy pathways. BMC Neurosci., 24.","DOI":"10.1186\/s12868-023-00832-1"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3168\/jds.2013-7761","article-title":"Efficiency of multi-breed genomic selection for dairy cattle breeds with different sizes of reference population","volume":"97","author":"Hoze","year":"2014","journal-title":"J. Dairy Sci."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Xiao, J., Kendal, E., and Kwa, F.A.A. (2024). Harnessing the Power of AI to Improve Detection, Monitoring, and Public Health Interventions for Japanese Encephalitis. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010042"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/12\/1204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:02:08Z","timestamp":1764158528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/12\/1204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":172,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["pathogens14121204"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14121204","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}